REDS Stock Overview
Develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Redsense Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 7.16 |
| 52 Week High | SEK 8.44 |
| 52 Week Low | SEK 4.51 |
| Beta | 0.49 |
| 1 Month Change | 13.65% |
| 3 Month Change | 16.99% |
| 1 Year Change | -10.50% |
| 3 Year Change | -65.90% |
| 5 Year Change | -49.75% |
| Change since IPO | 50.74% |
Recent News & Updates
Recent updates
Here's Why We're Watching Redsense Medical's (NGM:REDS) Cash Burn Situation
Jun 15
Redsense Medical (NGM:REDS) Is In A Good Position To Deliver On Growth Plans
Mar 01We're Not Very Worried About Redsense Medical's (NGM:REDS) Cash Burn Rate
Nov 10Is Redsense Medical (NGM:REDS) In A Good Position To Deliver On Growth Plans?
Apr 20Shareholders Are Thrilled That The Redsense Medical (NGM:REDS) Share Price Increased 236%
Feb 24Shareholder Returns
| REDS | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 7.5% | 0.4% | -2.7% |
| 1Y | -10.5% | -8.1% | 4.6% |
Return vs Industry: REDS underperformed the Swedish Medical Equipment industry which returned -8.1% over the past year.
Return vs Market: REDS underperformed the Swedish Market which returned 4.6% over the past year.
Price Volatility
| REDS volatility | |
|---|---|
| REDS Average Weekly Movement | 10.1% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.3% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: REDS's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: REDS's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 5 | Sebastien Bollue | redsensemedical.com |
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flow when the alarm unit detects a blood leakage.
Redsense Medical AB (publ) Fundamentals Summary
| REDS fundamental statistics | |
|---|---|
| Market cap | SEK 117.75m |
| Earnings (TTM) | -SEK 6.24m |
| Revenue (TTM) | SEK 24.22m |
4.9x
P/S Ratio-18.9x
P/E RatioIs REDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| REDS income statement (TTM) | |
|---|---|
| Revenue | SEK 24.22m |
| Cost of Revenue | SEK 9.90m |
| Gross Profit | SEK 14.32m |
| Other Expenses | SEK 20.56m |
| Earnings | -SEK 6.24m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.38 |
| Gross Margin | 59.14% |
| Net Profit Margin | -25.76% |
| Debt/Equity Ratio | 0% |
How did REDS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 04:19 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Redsense Medical AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Maria Karlsson Osipova | Penser Access |